The first patient was dosed in a phase 3 trial of IBI354 for platinum-resistant ovarian cancer with HER2 expression.

The forum celebrated the success of a three-year effort that resulted in KAIMRC kicking off the first phase I clinical trial in Saudi Arabia, testing a potential vaccine against MERS-CoV.

The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

A new drug application for povorcitinib is expected to be filed in late 2025 to early 2026 to treat adult patients with ...

Q4 2024 Management View CEO Jim Brown emphasized the company’s focus on advancing larsucosterol, their lead asset for treating alcohol-associated hepatitis (AH). He highlighted the significant unmet ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

Research studies explore the different factors that affect health and lead to disease. Clinical trials test the safety and effectiveness of new cancer drugs and treatments. They help us find better ...